CATALYST PHARMACEU earnings per share and revenue

CN2 earnings per share for the last quarter are 0.40 CHF whereas the estimation was 0.31 CHF which accounts for 29.96% surprise. Company revenue for the same period amounts to 128.79 M CHF despite the estimated figure of 121.85 M CHF. Estimated earnings per share for the next quarter are 0.30 CHF, and revenue is expected to reach 116.40 M CHF. Also watch annual changes over time to get a bigger picture of CN2 earnings per share and revenue dynamics.